“…The power of dynamic metabolic probing using HP 13 C MR is compelling, as it allows the measuring of previously inaccessible metabolic reactions noninvasively. HP 13 C metabolic imaging is a rapidly growing field, and is now being used in multiple clinical trials across the globe, targeting several organs, including the brain, heart, prostate, and kidney [ 28 , 29 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 ]. It is very likely that, given the constant improvements reported, both on the acquisition and processing sides, this methodology will soon approach feasibility for widespread clinical adoption.…”